Essential Oil Compounds Research in Cancer Treatment, GreenMedInfo

Pinterest may ban GreenMedInfo articles but NHPPA shares in solidarity. Sayer Ji’s work is dedicated to news and information about natural health. The Christmas season brought attention to frankincense and mistletoe. Both have been studied in recent years and found to be effective against killing certain cancer cells, on their own, and as a support when used in conjunction with chemotherapy treatments. We found two (of many) articles circulating about some scientific research on the essential oil chemical constituents of these plants.

In a December 20, 2013 article (2 minute read) by Ken McGowan for GreenMedInfo, “Frankincense Superior to Chemotherapy in Killing Late-Stage Ovarian Cancer Cells”, we learn about the University of Leicester’s research using a frankincense compound from resin, AKBA, on late stage ovarian cancer cells. Researchers found it surprising that “cells we have tested which are resistant to chemotherapy have shown to be more sensitive to this compound, suggesting frankincense may indeed be able to help overcome drug resistance, and lead to an improved survival rate for patients with late-stage ovarian cancer.”

In a December 25, 2017 article (2.5 minute read) by the GreenMedInfo Research Group, “Mistletoe Extract Beats Chemotherapy Against Colon Cancer Cells”, they tell us that several extract studies have been done on different types of cancer. It’s encouraging to see that “European doctors have considered mistletoe extracts a viable alternative treatment for various cancers. Mistletoe extract is already authorized for use by sufferers of colon cancer in Europe, but not in the United States.”